Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy - Concepedia

Concepedia

Publication | Open Access

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy

DOI Full Paper Access

70

Citations

58

References

2015

Year

Betsy T. Kren, Gretchen M. Unger, Md. Joynal Abedin, Rachel I. Vogel, Christine Henzler, Khalil Ahmed, Janeen H. Trembley

Breast Cancer Research

References

	Year	Citations

Page 1